Cardiac Glycosides Drive Immune Remodeling and Ferroptosis‐Associated Immunogenic Cell Death in Multiple Myeloma

ABSTRACT Although immunotherapies have improved outcomes in multiple myeloma (MM), therapeutic resistance remains a major challenge, thereby underscoring the need for strategies that enhance tumor immunogenicity. Here, we show that cardiac glycosides (CGs), including periplocin and digoxin, act as immunogenic sensitizers in MM. CG treatment upregulated the cell‐surface expression of ICAM‐1, 4‐1BBL, and SLAMF7 in MM cell lines and primary patient‐derived CD138 + cells. Mechanistically, our findings support the involvement of Na + /K + ‐ATPase inhibition, Ca 2+ signaling, and mitochondrial‐ and endoplasmic reticulum (ER)‐associated ROS pathways in CG‐induced immune remodeling. CGs also induced immunogenic cell death (ICD)‐associated changes, including cell‐surface calreticulin exposure and extracellular HMGB1 and ATP release. These changes were associated with ferroptosis, as indicated by intracellular Fe 2+ accumulation, lipid peroxidation, elevated malondialdehyde levels, and attenuation of ICD markers by ferroptosis inhibitors. Functionally, CG treatment enhanced the cytotoxic effects of elotuzumab and teclistamab by promoting effector T‐ and NK‐cell‐mediated killing. Collectively, our findings suggest that the Na + /K + ‐ATPase–Ca 2+ –ROS axis contributes to immune remodeling and ferroptosis‐associated ICD in MM. These results provide mechanistic insights into stress‐induced tumor immunogenicity and support further investigation of CGs as sensitizers for antibody‐based immunotherapy in MM.

Authors

Institutions

Publication Details

Journal
Cancer Science
Published
2026-11-17
DOI
https://doi.org/10.1111/cas.70596
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cardiac Glycosides Drive Immune Remodeling and Ferroptosis‐Associated Immunogenic Cell Death in Multiple Myeloma

Masaki Ri, Takahiro Nakashima, Tomotaka Suzuki, Hidetoshi Hayashi et al.
Cancer Science
Multiple Myeloma Research and Treatments
article

Cardiac Glycosides Drive Immune Remodeling and Ferroptosis‐Associated Immunogenic Cell Death in Multiple Myeloma

Masaki Ri, Takahiro Nakashima, Tomotaka Suzuki, Hidetoshi Hayashi, Toru Ebina, Takaomi Sanda, Yoshiaki Marumo, Shiori Kinoshita, Yasumichi Inoue, Yoshiko Oshima, Shinsuke Iida, Hirokazu Sasaki, Hirokazu Komatsu, Chie Kato, Tomoyuki Nakamura
article en

Abstract

ABSTRACT Although immunotherapies have improved outcomes in multiple myeloma (MM), therapeutic resistance remains a major challenge, thereby underscoring the need for strategies that enhance tumor immunogenicity. Here, we show that cardiac glycosides (CGs), including periplocin and digoxin, act as immunogenic sensitizers in MM. CG treatment upregulated the cell‐surface expression of ICAM‐1, 4‐1BBL, and SLAMF7 in MM cell lines and primary patient‐derived CD138 + cells. Mechanistically, our findings support the involvement of Na + /K + ‐ATPase inhibition, Ca 2+ signaling, and mitochondrial‐ and endoplasmic reticulum (ER)‐associated ROS pathways in CG‐induced immune remodeling. CGs also induced immunogenic cell death (ICD)‐associated changes, including cell‐surface calreticulin exposure and extracellular HMGB1 and ATP release. These changes were associated with ferroptosis, as indicated by intracellular Fe 2+ accumulation, lipid peroxidation, elevated malondialdehyde levels, and attenuation of ICD markers by ferroptosis inhibitors. Functionally, CG treatment enhanced the cytotoxic effects of elotuzumab and teclistamab by promoting effector T‐ and NK‐cell‐mediated killing. Collectively, our findings suggest that the Na + /K + ‐ATPase–Ca 2+ –ROS axis contributes to immune remodeling and ferroptosis‐associated ICD in MM. These results provide mechanistic insights into stress‐induced tumor immunogenicity and support further investigation of CGs as sensitizers for antibody‐based immunotherapy in MM.

Cancer Science
Nagoya City University (JP)
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon